7:30 CEST our Q2 2022 financial results will be released. The
company announcement will be available here
Get all the details and materials you need to attend our conference calls or just listen in via live webcasts.
7:30 CEST our Q3 2022 financial results will be released. The
company announcement will be available here
Get all the details and materials you need to attend our conference calls or just listen in via live webcasts.
Watch the presentations and get the slides from the Novo Nordisk Capital Markets Day.
5 June: Investor event (ADA 82nd Scientific Sessions)
Presentation (Webcast)
Presentation (pdf)
- Annual report 2021 (UK) | 2021 i tilbageblik (DK)
- Company announcement
- Investor presentation
- Financial workbook
- Conference call webcast (02 February 2022, 13.00 CET)
- Conference call audio link (02 February 2022, 13.00 CET)
- London earnings presentation webcast (04 February 2022, 12.00 CET)
- London earnings presentation audio link (04 February 2022, 12.00 CET)
- Company announcement
- Investor presentation
- Financial workbook
-
Conference call webcast (03 November 2021,
13.00 CET)
- Conference call audio link (03 November 2021, 13.00 CET)
- London Webcast (04 November 2021, 14.15 CET)
- London earnings presentation audio link (04 November 2021, 14.15 CET)
- Company announcement
- Investor presentation
- Financial workbook
- Conference call webcast (04 August 2021, 13:00 CEST)
-
Conference call audio link (04 August 2021,
13:00 CEST)
- London webcast (06 August 2021, 13:00 CEST)
- London earnings presentation audio link (06 August 2021, 13:00 CEST)
Conference call webcast (05 May 2021, 13:00 CET)
Conference call audio link (05 May 2021, 13:00 CET)
London webcast (06 May 2021, 13:00 CET)
London earnings presentation audio link (06 May 2021, 13:00 CET)
20 December: Conference call on supply situation for Wegovy®
Presentation (Webcast)
Presentation (pdf)
28 June: R&D investor call
Presentation (Webcast)
Presentation (pdf)
07 June: Approval of Wegovy™ in the US
Presentation
(Webcast)
Presentation (pdf)
21 May: International Operations call
Presentation
(Webcast)
Presentation (pdf)
- Annual report 2020 (UK)
-
Company
announcement
- Novo Nordisk CEO reflects on the full year results (video)
- Investor presentation
-
Conference call webcast (03 February 2021,
13:00 CET)
- Conference call audio link (03 February 2021, 13:00 CET)
- London webcast (05 February 2021, 12:00 CET)
- London earnings presentation audio link (05 February 2021, 12:00 CET)
- Financial workbook
- Company Announcement
- Investor presentation
- Conference call webcast (30 Oct 2020, 13:00 CET)
- Conference call audio link (30 Oct 2020, 13:00 CET)
- London webcast (2 Nov 2020, 13:00 CET)
- London earnings presentation audio link (2 Nov 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call webcast (6 Aug 2020, 13:00 CET)
- Conference call audio link (6 Aug 2020, 13:00 CET)
- London webcast (7 Aug 2020, 13:00 CET)
- London earnings presentation audio link (7 Aug 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call
webcast (6 May 2020, 13:00 CET)
- Conference call audio link (6 May 2020, 13:00 CET)
- London webcast (7 May
2020, 13:00 CET)
- London earnings presentation audio link (7 May 2020, 13:00 CET)
- Financial workbook
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
30 November: ESG conference call
- Presentation (webcast)
-
ESG presentation (pdf)
- Introduction
- Circular for Zero followed by Q&A
- Defeat Diabetes and Sustainable Workplace followed by Q&A
- Governance structure followed by
Q&A
9 October: Novo Nordisk raises sales and operating profit outlook
for 2020
19 June: R&D investor presentation
26 March: Annual General Meeting
- Conference call webcast (5 February, 13:00 CET)
- London webcast (6 February, 14:15 CET)
- Conference call webcast (1 November, 13:00 CEST)
- London webcast (4 November, 14:15 CEST)
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}
